Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Dan had no honor. He was a liar. In 2013 the company put out a PR saying it was withdrawing the controversial comp proposal in the proxy because it was committed to aligning with investors, then months later Dan put the same proposal right back on the table and rammed it through via deceptive means that devalued shareholders by 40%.